Resistance Training

Resistance training (RT), lifting weights or working against other resistance to build muscle and strength, has one of the strongest mortality-reduction evidence bases of any exercise modality, distinct from and additive to cardiovascular exercise.

Momma and colleagues' 2022 meta-analysis found any regular resistance training reduces all-cause mortality by 15% (relative risk 0.85, 95% CI 0.77-0.93), cardiovascular mortality by 19%, and cancer mortality by 14% [1]. Saeidifard and colleagues, pooling data on 370,256 people, found RT alone associated with 21% lower all-cause mortality (hazard ratio 0.79) and RT combined with aerobic exercise with 40% lower mortality (hazard ratio 0.60), though the cancer-mortality association did not reach significance in their pooled analysis [2].

A Danish study of adults at retirement age (the LISA study, N=451) found one year of heavy resistance training maintained isometric leg strength at four-year follow-up, while moderate-intensity training and no-training control groups both showed measurable strength decline over the same period [3]. This is a rare example of RT's benefit persisting well past the active training period.

The featured counter-finding, and a genuinely underappreciated one: a European review identified a U-shaped dose-response relationship, with optimal mortality benefit around 60 minutes of resistance training per week, and diminishing or even reversing benefit above about 150 minutes per week [4]. More is not simply better; RT appears to follow the same inverted-U pattern seen with several other exercise modalities, where very high volumes stop adding benefit and may start reducing it in the pooled cohort data.

Who this does not work for, or where the evidence is weakest: a 2026 Frontiers in Public Health meta-analysis of 12 RCTs (N=518) in older women with sarcopenia found RT improved strength and physical function but did not significantly improve muscle mass indicators (skeletal muscle index) [5]. That is a meaningful gap for a population, frail older women, for whom muscle mass itself is often the stated treatment target, rather than strength or function alone. People with uncontrolled hypertension, recent cardiac events, or certain joint injuries need individualized programming rather than generic heavy-lifting protocols. The mortality-reduction cohort data, while large, remain observational; people who resistance train differ from those who do not in ways beyond the exercise itself, health status, income, access to gyms, that adjustment can only partly address.

Mechanistically, RT preserves and builds skeletal muscle mass and strength, both directly protective against frailty and falls, and improves insulin sensitivity and metabolic health independent of aerobic fitness gains, linking it to nutrient-sensing and mitochondrial-biogenesis pathways relevant to the broader hallmarks of aging.

Plain takeaway: resistance training reduces all-cause mortality by 15-21% in large pooled analyses, with the largest benefit when combined with aerobic exercise, but the dose-response is U-shaped, roughly 60 minutes a week appears optimal, and its benefit for actual muscle mass gain in frail older populations is weaker than its benefit for strength and function.